Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0015672 (fatigue)
 51,768 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Twenty-three patients with low natural killer syndrome (LNKS), 7 males and 16 females, are reported here. These LNKS patients had an age range from 14 to 77 years, with a median of 36.5 years. LNKS is a newly proposed category of immune disorders, being characteristically diagnosed by lowered NK cell activity against K562 target cells as a definite laboratory abnormality, in association with general clinical symptoms of remittent fever and uncomfortable fatigue, persisting without explanation for more than 6 months. Other immune parameters, such as the DNA synthesis of peripheral blood mononuclear cells (PBMCs) in either the presence or absence of mitogens, the T4+/T8+ ratio and the number of Leu-11+ PBMCs, were usually within the normal range. Also, routine laboratory tests did not detect any abnormal findings. The LNKS patients responded well to the administration of an immunopotentiator called 'lentinan', a glucan extracted from the Japanese mushroom Lentinus edodes, despite no responses to conventional fever treatments such as the administration of antipyretics or antibiotics. All LNKS patients observed were universally free of antibodies in their sera to human T-lymphotropic retroviruses I and III, and lymphadenopathy was infrequent, indicating that the LNKS is a syndrome independent of acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. Antibodies to other known viruses tested such as Epstein-Barr or measles virus, or cytomegalovirus were also negative or not significantly elevated in the sera before the initiation of lentinan administration. If a virus is the cause of LNKS, it may be a new, unknown virus or an unknown substrain of known viruses. None of the LNKS patients has died of this syndrome.
 ...
PMID:Low natural killer syndrome: clinical and immunologic features. 244 2

A placebo-controlled study of varicella vaccine given either with or 6 weeks after measles-mumps-rubella (MMR) vaccine was undertaken in healthy children (mean age 16 months). A total of 101 varicella-zoster virus antibody-negative children completed the study. Serologic response to MMR vaccine was excellent (nearly 100%) and not significantly affected by the administration of varicella vaccine. Seroconversion in response to varicella vaccine was excellent and was not affected by MMR vaccine. No significant differences in fever or skin rashes between those receiving MMR vaccine with varicella vaccine or MMR vaccine with placebo were noted, but fever and skin rashes were more frequent after the first immunization (MMR with varicella vaccine or MMR vaccine with placebo) compared with the second (varicella vaccine or placebo injection). Symptoms of fatigue, irritability, and upper respiratory tract infections were more common after MMR vaccine was given regardless of whether it was given simultaneously with varicella vaccine or placebo injection.
 ...
PMID:Placebo-controlled trial of varicella vaccine given with or after measles-mumps-rubella vaccine. 253 73

A cluster of 134 patients who had undergone Epstein-Barr virus (EBV) serological testing because of suspected chronic EBV syndrome was investigated in Nevada. Fifteen case-patients were identified who had severe, persistent fatigue of undetermined etiology for more than two months. When compared with the remaining 119 patients who had less severe illnesses and with 30 age-, sex-, and race-matched control-persons, these 15 patients had significantly higher antibody titers against various components of EBV and against cytomegalovirus and herpes simplex and measles viruses. Epstein-Barr virus serology could not reliably differentiate individual case-patients from the others, and the reproducibility of the tests within and among laboratories was poor. As a group, the case-patients appear to have had a syndrome that is characterized by chronic fatigue, fever, sore throat, and lymphadenopathy. The relationship of this fatigue syndrome to EBV is unclear; further studies are needed to determine its etiology.
 ...
PMID:A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? 303 37

A community-based malaria control programme was initiated in Saradidi, Kenya. One factor determining the utilization of treatment would be the symptoms felt to be diagnostic of malaria. The 12 most common diseases and 29 most common symptoms were identified by community members. Thirty-six randomly selected women were interviewed to determine association of the common diseases and symptoms; nine women were aged 15 to 29 years, nine women were 30 to 40 years, nine were 45 to 59 years and nine were 60 years or more. Women 60 years and older recognized a higher proportion of the diseases (P less than 0.0005) when compared with the other women of other ages. More than 90% of the women associated headache, fever, vomiting, joint pain, loss of appetite, tiredness and death with malaria. Measles and influenza were distinguished from malaria by rash and mouth ulcer for measles and by 'runny nose' and 'sneezing' for influenza. Analysis by average linkage hierarchical clusters revealed that malaria, influenza and measles were distinguished readily. The results suggest that if people in Saradidi do not obtain treatment from community health workers, it is not because they do not recognize the clinical symptoms of malaria.
 ...
PMID:Symptoms associated with common diseases in Saradidi, Kenya. 368 33

A patient suffering from acute lymphoblastic leukemia, in complete remission for two years, is treated for haematologic relapse with V.P.D. and C.O.A.P. consolidation. After this treatment, develops tiredness, sleepiness, a slight fever and cough, dying some days after, of interstitial pneumonia. Post-mortem anatomic-pathological studies, show giant cell multinucleated pneumopathia, with intranuclear inclusions bodies, that in ultrastructural level resembles paramyxovirus. When this complication took place, the patient had a brother with measles, but he hasn't, the typical symptomatology of said virus disease. According to Siegel, authors point out the frequency of death due to interstitial pneumonia as a complication caused by measles in immunodeficient patients, remarking the importance of an immediate diagnosis and its' prophylaxis.
 ...
PMID:[Giant cell pneumonia. Complication in one case of acute lymphoblastic leukemia (author's transl)]. 693 58

An adult woman with catarrhal measles developed idiopathic ketosis. The contributing factors were: diet noncompliance (taking meat rich in fat), emotional stress and fatigue, acute infection (measles).
 ...
PMID:[A case of an unusual course in measles]. 857 Dec 42

A system for the automatic analysis of 24-well plates used in antibody assays to measles virus has been designed and developed based on digitising the information on the plate through a CCD camera, displaying the image and then analysing it using image processing methods. The system is being used in the analysis of sera from individuals vaccinated against measles and has been compared with the previous method where the plates were assessed by eye. The results from both methods are very similar although the manual method consisted of counting numbers of plaques (clear areas in the cells of the plate) and the automatic method measured plaque area. The automatic method is much faster than the original method and prevents operator fatigue. It does not deal, at present, with anomalies such as partially filled wells but could be developed to do so by incorporating intelligence into the system.
 ...
PMID:Automatic image analysis of antibody assays to measles virus. 864 42

The post-Q-fever fatigue syndrome (QFS) (inappropriate fatigue, myalgia and arthralgia, night sweats, changes in mood and sleep patterns) follows about 20% of laboratory-proven, acute primary Q-fever cases. Cytokine dysregulation resulting from chronic immune stimulation and modulation by persistence of Coxiella burnetii cells or their antigens is hypothesized. We studied cytokine release patterns of peripheral blood mononuclear cells (PBMC) stimulated with various ligands in short-term culture, from 18 patients with active QFS, and 27 controls: six with resolving QFS, five who had had acute primary Q-fever without subsequent QFS, eight healthy Q-fever vaccinees and eight healthy subjects without Q-fever antibody. Conditioned media (CM) from PBMC stimulated in short-term culture with Q-fever antigens, PHA or measles antigen (as an unrelated antigen) were assayed for IL-2, IL-4, IL-5, IL-6, IL-10 and IFN gamma by AgEIA, and for IL-1 and TNF alpha/beta by bioassay. Aberrant cytokine release patterns were observed with PBMC from QFS patients when stimulated with Q-fever antigens: an accentuated release of IL-6 which was significantly [p = 0.01, non-parametric one-way analysis of variance (ANOVA)] in excess of medians for all four control groups. With IL-2, the number of responders in the active QFS group was decreased relative to control groups (Fisher's exact test, p = 0.01) whereas the number of IFN gamma responders was increased (Fisher's exact test, p = 0.0008). Significant correlations were observed between concentrations of IL-6 in CM, total symptom scores, and scores for other key symptoms.
 ...
PMID:Cytokine dysregulation in the post-Q-fever fatigue syndrome. 1061 86

Although vaccines exist against almost 30 different diseases and work remains ongoing on additional new vaccines, many of the currently existing and used vaccines are far from ideal. The vaccines being used by the World Health Organization's (WHO) Expanded Program on Immunization (EPI) against the common childhood diseases of diphtheria, whooping cough, neonatal tetanus, measles, and tuberculosis are reaching 80% of the world's children and saving an estimated 3 million of them annually from death. However, of the almost 13 million child deaths which occur every year, more than 2 million die from vaccine-preventable diseases. Immunization coverage must be improved. Finding sufficient funds to allow immunization programs to sustain their current level of coverage is already difficult and becoming more difficult due to rising vaccine and vaccine delivery costs, donor fatigue, and competing demands upon health and development resources. A super-vaccine is therefore needed which contains in 1 dose all of the antigens required for lifelong protection against the most life-threatening and disabling diseases. The move toward this goal has begun with the development of combination vaccines. A brief historical overview of the development of combination vaccines is presented, followed by consideration of the advantages of combination vaccines and the Children's Vaccine Initiative (CVI) strategy of building upon the diphtheria-tetanus-pertussis (DTP) vaccine.
 ...
PMID:Combinations, the key to global immunization. 1229 17

The therapeutic uses of hive-derived products by local people in four zones from the central part of Burkina Faso are described. Of 13 apitherapeutic applications recorded, only honey (12) and honeybee larvae (1) were used. The uses described included treatment of various gastrointestinal disorders, respiratory ailments, fatigue, vertigo, ophthalmic disorders, toothache, measles, wounds, burns, chest pains, period pains and postnatal disorders, male impotence as well as its application as a skin cleansing agent. The effectiveness against some of these conditions, e.g. measles, period pains and postnatal disorders, requires further investigation and confirmation.
 ...
PMID:Therapeutic uses of honey and honeybee larvae in central Burkina Faso. 1537 14


1 2 Next >>